3-(5-bromo-2-methoxyphenyl)propanoic acid, 95.0%, 10g

4-[(5-chloropyridin-2-yl)oxy]benzoic acid, 95%, 500mg

Mono-potassium citrate, min. 99%, pure, anhydrous, 1 kg, plastic packaging.

N-(4-piperidinylmethyl)acetamide hydrobromide, 95.0%, 50g

(S)-tert-Butyl 3-(2-methoxy-2-oxoethyl)piperidine-1-carboxylate, 97%, 100mg

Fmoc-Met-OH, 98%, 100g

5-BROMO-2-CHLORO-N-METHYL-3-NITROPYRIDIN-4-AMINE, 95.0%, 250mg

(R)-(-)-3-Hydroxytetrahydrofuran, 98.0%, 5g

ethyl 2-((5R)-5-isopropyl-3,6-dimethoxy-2,5-dihydropyrazin-2-yl)acetate, 98%, 500mg

(2-BENZYLISOINDOLIN-5-YL)METHANOL, 95.0%, 1g

Propanoic acid, 2-[[4-[2-[[(cyclohexylamino)carbonyl](4-cyclohexylbutyl)amino]ethyl]phenyl]thio]-2-methyl-, 98%, 25mg

Methyl 2-hydroxy-2-(pyridin-3-yl)acetate hydrochloride, 95%, 5g

Methyl 4-chloro-1H-indole-3-carboxylate, 250mg